Congress’ biotech panel pitches FDA policy upgrades to help performancenews2026-01-13T05:01:10+00:00January 13th, 2026|Endpoints News|
Pretzel buys Rome and its ‘dark genome’ worknews2026-01-12T21:37:31+00:00January 12th, 2026|Endpoints News|
Nvidia-partnered startup reveals AI-generated enzymes for precise gene insertionnews2026-01-12T21:18:10+00:00January 12th, 2026|Endpoints News|
#JPM26: Novo Nordisk CEO says pharma can learn from the GLP-1 compounding boomnews2026-01-12T20:55:09+00:00January 12th, 2026|Endpoints News|
At FDA’s request, Pfizer helps ease shortage of potential autism drugnews2026-01-12T19:49:26+00:00January 12th, 2026|Endpoints News|
FDA shares eased manufacturing rules for cell and gene therapiesnews2026-01-12T18:04:55+00:00January 12th, 2026|Endpoints News|
FDA lifts partial hold on Merck, Daiichi’s Phase 3 lung cancer studynews2026-01-12T17:47:28+00:00January 12th, 2026|Endpoints News|
Walmart makes tepid return to healthcarenews2026-01-12T17:43:40+00:00January 12th, 2026|Endpoints News|
Eisai licenses Nuvation lung cancer pill; Alnylam’s stock dips after sales data reportnews2026-01-12T16:22:25+00:00January 12th, 2026|Endpoints News|
AbbVie jumps into PD-1xVEGF bispecific race, pays $650M upfront to RemeGennews2026-01-12T15:41:14+00:00January 12th, 2026|Endpoints News|
